← Back to directory

Henry Masur

Researcher Next ID · RN-022514

Researcher · Medicine

National Institutes of Health

Bethesda, Switzerland

Not currently recruitingFunding unknown
Works count
564
Citation count
62,121
H-index
108
i10-index
348

Research interests

Medicine
Immunology and Microbiology
Pneumocystis jirovecii pneumonia detection and treatment
HIV/AIDS drug development and treatment
Hepatitis C virus research
HIV Research and Treatment
HIV/AIDS Research and Interventions

Publications

  • Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021

    Critical Care Medicine · 2021 · https://doi.org/10.1097/ccm.0000000000005337

  • Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021

    Critical Care Medicine · 2021 · https://doi.org/10.1097/ccm.0000000000005357

  • Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

    Intensive Care Medicine · 2021 · https://doi.org/10.1007/s00134-021-06506-y

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Clinical Infectious Diseases · 2019 · https://doi.org/10.1093/cid/ciz1008

  • Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

    JAMA · 2013 · https://doi.org/10.1001/jama.2013.109309

  • HIV-Associated Pneumocystis Pneumonia

    Proceedings of the American Thoracic Society · 2011 · https://doi.org/10.1513/pats.201009-062wr

  • Guidelines for the Prevention of Intravascular Catheter-related Infections

    Clinical Infectious Diseases · 2011 · https://doi.org/10.1093/cid/cir257

  • Summary of Recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections

    Clinical Infectious Diseases · 2011 · 10.1093/cid/cir138

  • Guidelines for the prevention of intravascular catheter-related infections

    American Journal of Infection Control · 2011 · 10.1016/j.ajic.2011.01.003

  • Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

    PsycEXTRA Dataset · 2009 · 10.1037/e537722009-001

  • Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America

    Critical Care Medicine · 2008 · 10.1097/ccm.0b013e318169eda9

  • Current Epidemiology ofPneumocystisPneumonia

    Emerging infectious diseases · 2004 · 10.3201/eid1010.030985

  • Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

    Intensive Care Medicine · 2004 · https://doi.org/10.1007/s00134-004-2210-z

  • Guidelines for the prevention of intravascular catheter-related infections

    American Journal of Infection Control · 2002 · 10.1067/mic.2002.129427

  • Guidelines for the Prevention of Intravascular Catheter–Related Infections

    Infection Control and Hospital Epidemiology · 2002 · 10.1086/502007

  • Guidelines for the Prevention of Intravascular Catheter-Related Infections

    PEDIATRICS · 2002 · 10.1542/peds.110.5.e51

  • Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

    PubMed · 2002

  • Guidelines for the Prevention of Intravascular Catheter–Related Infections

    Clinical Infectious Diseases · 2002 · 10.1086/344188

  • HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Proceedings of the National Academy of Sciences · 1999 · 10.1073/pnas.96.26.15109

  • HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

    Nature Medicine · 1997 · 10.1038/nm0597-533

  • Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

    New England Journal of Medicine · 1995 · 10.1056/nejm199503023320904

  • CD4 Counts as Predictors of Opportunistic Pneumonias in Human Immunodeficiency Virus (HIV) Infection

    Annals of Internal Medicine · 1989 · 10.7326/0003-4819-111-3-223

  • Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi

    Nature · 1988 · 10.1038/334519a0

  • Impaired Production of Lymphokines and Immune (Gamma) Interferon in the Acquired Immunodeficiency Syndrome

    New England Journal of Medicine · 1984 · 10.1056/nejm198404053101404

  • Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

    New England Journal of Medicine · 1983 · 10.1056/nejm198308253090803

  • An Outbreak of Community-AcquiredPneumocystis cariniiPneumonia

    New England Journal of Medicine · 1981 · 10.1056/nejm198112103052402

Current projects

    No projects listed.